# Estimated Lifetime Benefit of Combined RAAS and SGLT2 Inhibitor Therapy in Patients with Albuminuric CKD without Diabetes

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/estimated-lifetime-benefit-of-combined-raas-and-sglt2-inhibitor-therapy-in/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Priya Vart,Muthiah Vaduganathan,Niels Jongs,Giuseppe Remuzzi,David C. Wheeler,Fan Fan Hou,Finnian R. Mc Causland,Glenn M. Chertow,Hiddo J.L. Heerspink |
| Citations | 80 |
| DOI | 10.2215/cjn.08900722 |
| Fields | Medicine |
| Open Access | true |
| OA Status | green |
| OA URL | https://research.rug.nl/en/publications/f7ffcbc2-0250-490e-b463-a6398e376295 |
| OpenAlex ID | https://openalex.org/W4309680920 |
| PMID | 36414316 |
| Type | article |
| Year | 2022 |

## Paper authors

- [Finnian R. Mc Causland](https://scholariq.org/researchers/finnian-r-mc-causland/)

## Paper journal

- [Clinical Journal of the American Society of Nephrology](https://scholariq.org/journals/clinical-journal-of-the-american-society-of-nephrology/)

## Paper primary topic

- [Diabetes Treatment and Management](https://scholariq.org/topics/diabetes-treatment-and-management/)

## Paper topics

- [Diabetes Treatment and Management](https://scholariq.org/topics/diabetes-treatment-and-management/)
- [Chronic Kidney Disease and Diabetes](https://scholariq.org/topics/chronic-kidney-disease-and-diabetes/)
- [Blood Pressure and Hypertension Studies](https://scholariq.org/topics/blood-pressure-and-hypertension-studies/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.